Comparative evaluation of comprehensive offline 2D-LC strategies coupled to MS for untargeted metabolomic studies of human urine

对结合质谱的离线二维液相色谱-质谱联用技术在人尿液非靶向代谢组学研究中的综合策略进行比较评价

阅读:1

Abstract

Out of the broad selection of analytical methods applied in metabolomic studies, liquid chromatography coupled to mass spectrometry (LC-MS) has the highest coverage potential. In that regard, the quality of the separation process is crucial for the analytical outcome. Reversed-phase (RP) and hydrophilic interaction liquid chromatography (HILIC) are widely applied, and the potential of various setups to combine these modes for more complementary data has been deeply explored. In our previous study on the orthogonality of LC conditions in the field of metabolomics, combinations of a mixed-mode phase with parallel RP and ion-exchange (IEX) properties and several HILIC columns exhibited the widest compound distributions in a two-dimensional (2D) separation space. For further performance evaluation, an offline comprehensive 2D-LC-TOF-MS (LC×LC-TOF-MS) system was set up with the mixed RP/IEX mode in the first dimension ((1)D) and HILIC mode in the second dimension ((2)D). The transfer of fractions to the HILIC column and the effect of offline fraction preparation procedures (dilution and evaporation approaches) were comparatively investigated by using reference substances. In addition, the separation performance of the offline LC×LC-TOF-MS system with and without offline fraction preparation was assessed in comparison to other common LC-TOF-MS strategies (direct flow injection DFI, 1D-LC, serial coupling LC) by the number of detectable features in a human urine sample. In conclusion, the direct transfer of 5 µL fraction volumes without offline treatment was the most promising approach for future application in untargeted metabolomic studies for marker identification from human urine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。